Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Projected Impact of Population-Wide Achievement of LDL Cholesterol <70 mg/dL on the Number of Recurrent Events Among US Adults with ASCVD.
McKinley EC, Bittner VA, Brown TM, Chen L, Exter J, Farkouh ME, Huang L, Jackson EA, Levitan EB, Orroth KK, Reading SR, Rosenson RS, Safford MM, Woodward M, Muntner P, Colantonio LD. McKinley EC, et al. Among authors: exter j. Cardiovasc Drugs Ther. 2023 Feb;37(1):107-116. doi: 10.1007/s10557-021-07268-x. Epub 2021 Oct 2. Cardiovasc Drugs Ther. 2023. PMID: 34599698
Ischemic Event Rates in Very-High-Risk Adults.
Colantonio LD, Shannon ED, Orroth KK, Zaha R, Jackson EA, Rosenson RS, Exter J, Mues KE, Muntner P. Colantonio LD, et al. Among authors: exter j. J Am Coll Cardiol. 2019 Nov 19;74(20):2496-2507. doi: 10.1016/j.jacc.2019.09.025. J Am Coll Cardiol. 2019. PMID: 31727288 Free article.
Lipid-Lowering Therapy Use and Intensification Among United States Veterans Following Myocardial Infarction or Coronary Revascularization Between 2015 and 2019.
Zheutlin AR, Derington CG, Herrick JS, Rosenson RS, Poudel B, Safford MM, Brown TM, Jackson EA, Woodward M, Reading S, Orroth K, Exter J, Virani SS, Muntner P, Bress AP. Zheutlin AR, et al. Among authors: exter j. Circ Cardiovasc Qual Outcomes. 2022 Dec;15(12):e008861. doi: 10.1161/CIRCOUTCOMES.121.008861. Epub 2022 Oct 14. Circ Cardiovasc Qual Outcomes. 2022. PMID: 36252093 Free PMC article.
Recurrent Atherosclerotic Cardiovascular Disease Events Potentially Prevented with Guideline-Recommended Cholesterol-Lowering Therapy following Myocardial Infarction.
Sakhuja S, Bittner VA, Brown TM, Farkouh ME, Levitan EB, Safford MM, Woodward M, Chen L, Sun R, Dhalwani N, Jones J, Kalich B, Exter J, Muntner P, Rosenson RS, Colantonio LD. Sakhuja S, et al. Among authors: exter j. Cardiovasc Drugs Ther. 2023 Apr 13. doi: 10.1007/s10557-023-07452-1. Online ahead of print. Cardiovasc Drugs Ther. 2023. PMID: 37052867
Estimated number and percentage of US adults with atherosclerotic cardiovascular disease recommended add-on lipid-lowering therapy by the 2018 AHA/ACC multi-society cholesterol guideline.
Alanaeme CJ, Bittner V, Brown TM, Colantonio LD, Dhalwani N, Jones J, Kalich B, Exter J, Jackson EA, Levitan EB, Poudel B, Wang Z, Woodward M, Muntner P, Rosenson RS. Alanaeme CJ, et al. Among authors: exter j. Am Heart J Plus. 2022 Sep;21:100201. doi: 10.1016/j.ahjo.2022.100201. Epub 2022 Aug 27. Am Heart J Plus. 2022. PMID: 37168932 Free PMC article.